Infectious Diseases

Tran PNT, Limothai U, Dinhuzen J, Tachaboon S, Sukmark T, Dokpong C, Roytrakul S, Haake DA, Srisawat N. MicroRNA Biomarkers and Host Response Pathways in[...]

By sjmartinez • January 12, 2025

Kinganda-Lusamaki E, Amuri-Aziza A, Fernandez-Nuñez N, Makangara-Cigolo JC, Pratt C, Vakaniaki EH, Hoff NA, Luakanda-Ndelemo G, Akil-Bandali P, Nundu SS, Mulopo-Mukanya N, Ngimba M, Modadra-Madakpa[...]

By sjmartinez • January 12, 2025

Thorp M, Phiri S, Phiri K, Robson I, Mphande M, Dovel K, Hoffman R. Brief Report: Stated Preferences for Long-Acting Injectable ART Among Mobile Men[...]

By sjmartinez • January 11, 2025

Chavez C, Lin K, Malveaux A, Gorin A, Brizuela S, Cheng QJ, Hoffmann A. IRF1 cooperates with ISGF3 or GAF to form innate immune de[...]

By sjmartinez • January 9, 2025

Ogawa L, Morinishi C, Multani A, Gaynor P, Beaird OE, Pham C, Schaenman JM. Real-World Comparison of Maribavir to Foscarnet for the Treatment of Cytomegalovirus[...]

By sjmartinez • January 8, 2025

Hernandez CJ, Sundar KG, Echegaray F, Cambou MC, Yang LZ, Segura ER, Gonçalves de Melo M, Santos BR, Varella IRDS, Nielsen-Saines K. The Benefits of[...]

By sjmartinez • January 8, 2025

Blair CS, Shoptaw SJ. Managing Stimulant Use Among People With HIV: Harm-Reduction Strategies From Behavior to Medication. Top Antivir Med. 2024 Dec 23;32(5):571-578. PMID: 39765236.

By sjmartinez • January 8, 2025

Galetti SC, Gadoth A, Halbrook M, Tobin NH, Ferbas KG, Rimoin AW, Aldrovandi GM. Historic smallpox vaccination and Mpox cross-reactive immunity: Evidence from healthcare workers[...]

By sjmartinez • January 4, 2025

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford[...]

By sjmartinez • January 3, 2025

Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe[...]

By sjmartinez • January 2, 2025